
A breast surgeon explains why patients should raise lymphedema with their care team at the start of treatment, and how early detection can make it reversible.
Rudolph Navari, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.
Rudolph Navari, director, Cancer Care Program in Central and South America, World Health Organization, professor of medicine, Indiana University School of Medicine-South Bend, discusses a study of olanzapine for the prevention of chemotherapy-induced nausea and vomiting (CINV) in patients receiving highly emetogenic chemotherapy.






